The association of familial Alzheimer's disease (FAD) with mutations in Alzheimer's amyloid precursor protein (APP) suggests important functions for APP in the central nervous system. Mutations in APP impair its function to confer resistance to apoptosis in cells under stress, and this may contribute to neurodegeneration in Alzheimer's disease (AD) brain, but the mechanisms involved are unknown. We examined the role of the late Simian virus 40 transcription factor (LSF), in anti-apoptotic APP pathways. We show that in APP-deficient B103 cells, expression of wild-type human APP (hAPPwt), but not of FAD-mutant APP, inhibited staurosporine (STS)-induced apoptosis. This inhibition was further enhanced by expression of LSFwt, although LSFwt alone was not sufficient to inhibit STS-induced apoptosis. In contrast, expression of dominant-negative LSF led to a marked increase in STS-induced cell death that was significantly blocked by hAPPwt. These effects of APP were accompanied by LSF nuclear translocation and dependent gene transcription. The activation of LSF is dependent on the expression of hAPPwt and is inhibited by the expression of dominant-negative forms of either phosphoinositide 3-kinase or Akt. These results demonstrate that LSF activation is required for the neuroprotective effects of APP via phosphoinositide 3-kinase/Akt signalling. Alterations in this pathway by aberrations in APP and/or LSF could promote neuronal loss in AD brain, due to secondary insults. Thus a link is established between APP and LSF and AD.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
March 2003
- PDF Icon PDF LinkFront Matter
Research Article|
March 15 2003
Late Simian virus 40 transcription factor is a target of the phosphoinositide 3-kinase/Akt pathway in anti-apoptotic Alzheimers amyloid precursor protein signalling
Tarek KASHOUR;
Tarek KASHOUR
∗Section of Cardiology, Department of Medicine, St. Boniface General Hospital, The University of Manitoba, 770 Bannatyne Avenue, Winnipeg, MB, Canada R3E 0W3
Search for other works by this author on:
Teralee BURTON;
Teralee BURTON
†The Dr John Foerster Centre for Health Research on Aging, Department of Biochemistry and Medical Genetics, St. Boniface General Hospital Research Centre, The University of Manitoba, 770 Bannatyne Avenue, Winnipeg, MB, Canada R3E 0W3,
Search for other works by this author on:
Alexander DIBROV;
Alexander DIBROV
‡Fort Richmond Collegiate, 99 Killarney Avenue, Winnipeg, MB, Canada R3T 3B3
Search for other works by this author on:
Francis M. AMARA
Francis M. AMARA
1
†The Dr John Foerster Centre for Health Research on Aging, Department of Biochemistry and Medical Genetics, St. Boniface General Hospital Research Centre, The University of Manitoba, 770 Bannatyne Avenue, Winnipeg, MB, Canada R3E 0W3,
1To whom correspondence should be addressed (e-mail [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
July 31 2002
Revision Received:
December 02 2002
Accepted:
December 10 2002
Accepted Manuscript online:
March 15 2003
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London ©2003
2003
Biochem J (2003) 370 (3): 1063–1075.
Article history
Received:
July 31 2002
Revision Received:
December 02 2002
Accepted:
December 10 2002
Accepted Manuscript online:
March 15 2003
Citation
Tarek KASHOUR, Teralee BURTON, Alexander DIBROV, Francis M. AMARA; Late Simian virus 40 transcription factor is a target of the phosphoinositide 3-kinase/Akt pathway in anti-apoptotic Alzheimers amyloid precursor protein signalling. Biochem J 15 March 2003; 370 (3): 1063–1075. doi: https://doi.org/10.1042/bj20021197
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |